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cal anatomy and terminology of the PPN region in a com-
panion paper. Here we focus on issues concerning surgical 
technique, imaging, and early side effects of surgery. The 
aim of this paper was to gain more insight into the reason-
ing for choosing specific techniques and to discuss short-
comings of available studies. Our data demonstrate the 
wide range in almost all fields which were investigated. 
There are a number of important challenges to be resolved, 
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 Abstract 
 The pedunculopontine nucleus (PPN) region has received 
considerable attention in clinical studies as a target for deep 
brain stimulation (DBS) in Parkinson disease. These studies 
have yielded variable results with an overall impression of 
improvement in falls and freezing in many but not all pa-
tients treated. We evaluated the available data on the surgi-
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such as identification of the optimal target, the choice of the 
surgical approach to optimize electrode placement, the im-
pact on the outcome of specific surgical techniques, the re-
liability of intraoperative confirmation of the target, and 
methodological differences in postoperative validation of 
the electrode position. There is considerable variability 
both within and across groups, the overall experience with 
PPN DBS is still limited, and there is a lack of controlled tri-
als. Despite these challenges, the procedure seems to pro-
vide benefit to selected patients and appears to be relative-
ly safe. One important limitation in comparing studies from 
different centers and analyzing outcomes is the great vari-
ability in targeting and surgical techniques, as shown in our 
paper. The challenges we identified will be of relevance 
when designing future studies to better address several 
controversial issues. We hope that the data we accumulated 
may facilitate the development of surgical protocols for 
PPN DBS.  © 2016 S. Karger AG, Basel 
 The pedunculopontine nucleus (PPN) region has been 
used in clinical studies as a target for deep brain stimula-
tion (DBS) in patients with Parkinson disease (PD) and 
gait disorders which were poorly responsive to medical 
treatment. As indicated in a companion paper, these 
studies have yielded variable results with an overall ten-
dency for improvement in falls and freezing in many but 
not all treated patients (see companion paper on surgical 
anatomy). It remains unclear whether the variability in 
published data is related to patient selection, patient anat-
omy, differences in surgical technique or programming 
for chronic stimulation. It is likely that also multiple oth-
er factors may influence outcome. 
 We analyzed data on surgical anatomy and terminol-
ogy of the PPN region in a companion paper. Here we 
focus on issues concerning surgical technique, imaging, 
and early side effects of surgery. The aim of this paper is 
to gain more insight into the reasoning for choosing spe-
cific techniques and to discuss shortcomings of available 
studies. Finally, this set of data is intended to form a foun-
dation for developing a core protocol to be used in PPN 
DBS surgery. 
 Methodological Approach 
 The MDS Pedunculopontine Nucleus DBS Working 
Group in collaboration with the World Society for Ste-
reotactic and Functional Neurosurgery (WSSFN) de-
fined four domains to be addressed with regard to their 
relevance for PPN DBS surgery: preoperative selection 
of patients and available rating scales, clinical outcome 
and DBS programming, surgical anatomy, and surgical 
technique. In order to address the domain surgical tech-
nique, the executive committee formulated several ques-
tions during a consensus conference concerning also 
postoperative imaging and side effects which were dis-
tributed to the co-authors of the paper. Specific topics 
included unilateral versus bilateral implantation of DBS 
electrodes, combining PPN with other targets, stereo-
tactic targeting, microelectrode recording, intraopera-
tive test stimulation, type of DBS electrode, local field 
potentials, intraoperative and early postoperative com-
plications, and postoperative imaging studies. A biblio-
metric analysis was performed in the PubMed database 
using the following key words: pedunculopontine nu-
cleus; deep brain stimulation; anatomy; physiology;
surgery. 
 Specific topics were assigned to groups of authors, 
and this work was accumulated and reviewed by the ex-
ecutive committee of the working group. Areas of dis-
agreement were discussed and modified accordingly un-
til a consensus could be reached. The literature was con-
tinuously updated during that process. 
 Rationales for Bilateral versus Unilateral PPN DBS  
 Preclinical Data 
 Semba and Fibiger  [1] showed in rodents that the PPN 
input from the brainstem reticular formation, the lateral 
hypothalamus, the zona incerta, the midbrain central 
gray, the ventral tegmental area, the substantia nigra pars 
compacta, and the substantia nigra pars reticulata is pri-
marily bilateral, but with an ipsilateral predominance. In 
contrast to those findings, other reports in rodents  [2] 
and primates  [3] have demonstrated that nucleus sub-
thalamicus (STN) projections to the PPN were exclusive-
ly ipsilateral. 
 Kita and Kita  [4] quantified the lateralization of pro-
jections from the PPN to the STN in rats. They observed 
that only 10% of projection neurons were cholinergic 
with a fivefold predominance of ipsilateral versus contra-
lateral fibers. The predominance of ipsilateral to contra-
lateral projections in the remaining noncholinergic pro-
jections was close to threefold. 
 In summary, projections from the basal ganglia and 
other structures to the PPN in rodents were predomi-
nantly unilateral. Those between PPN and the STN ap-
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peared to be bilateral, with a stronger ipsilateral represen-
tation. Although no data exist in humans, preclinical 
findings suggest that, even though unilateral surgery may 
influence both sides of the body, it may likely have a 
stronger impact on the contralateral side. 
 Clinical Data 
 Clinical insight into the safety and efficacy of unilat-
eral versus bilateral PPN stimulation has been limited. 
Unilateral DBS has been carried out in two series with 6 
 [5] and 13 patients  [6] treated in different centers. In con-
trast, bilateral DBS was conducted in various other trials. 
After an initial study with 2 individual patients  [7] , 2 se-
ries of 6 subjects were reported in which bilateral PPN 
DBS was delivered along with STN DBS  [8, 9] . Another 
series of 5 patients was reported with bilateral PPN DBS 
administered in tandem with DBS in the caudal zona in-
certa (cZI)  [10] . A recent study which included a double-
blind randomized study protocol applied bilateral DBS to 
the anterior PPN  [11, 12] . 
 Imaging studies in PD patients suggest that unilateral 
PPN DBS increases cerebral blood flow bilaterally into 
the central thalamus and cerebellum  [13] . Formal com-
parisons between unilateral and bilateral PPN DBS, how-
ever, tend to support bilateral DBS  [14] . Khan et al.  [14] 
showed that on-medication UPDRS motor scores im-
proved by 5.7% with unilateral PPN DBS and by 18.4% 
with bilateral PPN DBS in a series of 5 PD patients. Simi-
larly, improvement in UPDRS axial subscores (items 27–
30) after unilateral PPN DBS was 22% and after bilateral 
PPN DBS 36%. 
 In an experimental study to measure the spatiotempo-
ral characteristics of gait during PPN DBS, Thevathasan 
et al.  [15] compared the effects of unilateral versus bilat-
eral stimulation in a blinded fashion. The authors found 
that improvement in freezing after bilateral stimulation 
of the caudal PPN in the off-medication condition was 
approximately twice as high as that recorded after unilat-
eral stimulation. 
 Conclusions 
 Both unilateral and bilateral PPN DBS were found to 
have an impact on gait and axial symptoms. Only 1 clini-
cal trial and 1 study on gait compared the effects of bilat-
eral versus unilateral PPN DBS directly. In both, bilateral 
stimulation proved to be superior, particularly for con-
trolling freezing of gait. Nevertheless, these findings need 
to be corroborated by additional studies with a longer fol-
low-up including a higher number of patients prior to 
specific recommendations. 
 Combination with Other Targets 
 While few PD patients present with a predominant 
gait disorder or freezing refractory to medical treatment, 
the majority of patients in whom DBS is considered suffer 
also from other parkinsonian symptoms. Chronic stimu-
lation of the PPN has been combined with stimulation of 
other targets, including the STN, the globus pallidus in-
ternus (GPi), and the cZI. There has been a different ra-
tionale for choosing each target with some evidence sug-
gesting that target combinations may be superior to PPN 
DBS alone. Combined stimulation poses a series of chal-
lenges for the assessment of the effects of DBS in each 
target, as well as for unlocking the understanding of the 
complex relationship between medication and stimula-
tion. A particular problem is the fact that, in general, most 
groups use low-frequency stimulation for the PPN and 
high-frequency stimulation in other targets. This regi-
men requires complex programming or the use of an ad-
ditional pulse generator. 
 In their initial trial, Stefani et al.  [8] implanted 6 PD 
patients with bilateral PPN and STN electrodes. This 
combined approach was selected to tailor DBS according 
to the patients’ symptoms – that is those typically con-
trolled by STN DBS and those considered as being STN 
stimulation refractory  [8] . Overall, the results showed a 
synergistic effect between targets. In a study from Greno-
ble, PPN DBS was added to STN DBS in 6 patients with 
advanced PD  [16] . The addition of PPN DBS reduced the 
duration of freezing episodes under the off-drug condi-
tion. Moreover, it reduced falls related to freezing. Total 
UPDRS scores, however, did not significantly change. 
 In another report, in 3 PD patients PPN DBS was com-
bined with GPi DBS with the rationale to treat off dysto-
nia as well as gait features  [6] . In a more recent study, it 
was demonstrated that low-frequency PPN DBS com-
bined with high-frequency GPi DBS in a patient with ad-
vanced PD had a marked impact on gait ignition and 
freezing of gait. In contrast, isolated PPN or GPi DBS 
yielded only mild effects with the patient trial being blind-
ed in each condition and by using a computerized gait 
analysis system  [17] . 
 Khan et al.  [10, 18] observed that the effects of com-
bined PPN and cZI DBS in 7 patients were superior to 
those of a single target. When both PPN and cZI elec-
trodes were bilaterally activated, motor scores improved 
by 41.8%. When receiving bilateral PPN and cZI DBS, 
UPDRS axial subscores improved by 58.3%. 
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 Conclusions 
 Only a few trials have studied the effects of combining 
PPN DBS with stimulation of the STN, GPi or cZI. Fur-
thermore, the small number of patients in each study
limits the interpretation of the data.
 Stereotactic Targeting 
 Target Site within the PPN 
 There is no consensus on the optimal target site with-
in the PPN region. There remains uncertainty as to 
whether electrodes should be implanted in the rostral 
PPN (at the level of the inferior colliculus, IC) or caudal 
PPN (in a region about 4 mm below the IC). Given the 
murkiness of the available data and since the PPN is ori-
ented along the long axis of the brainstem, a reasonable 
approach would be to have contacts in both rostral  and 
caudal PPN regions. 
 It should be noted, however, that in animal studies of 
PPN stimulation-induced locomotion, the activation of 
the posterior pars compacta was efficacious while stimu-
lation of the anterior PPN was not  [19, 20] . A recent study 
on an animal model of PD showed that stimulation of the 
anterior PPN induced freezing and worsened gait, but 
gait was improved by posterior PPN stimulation  [21] . 
 Targeting of PPN across Different Groups 
 Below, we summarize the methods used by different 
investigators to target the PPN. Stereotactic imaging con-
sisted of either MRI alone or combined with CT  [10, 18] . 
 Bristol, UK  [7, 22] . T2-weighted MRI and proton den-
sity sequences were used. The PPN was defined on an 
axial plane acquired parallel to that formed by the upper 
border of the pons and the midbrain collicular point. In 
that section, the PPN was localized between the decussa-
tion of the superior cerebellar peduncle and the medial 
lemniscus. The nucleus was suggested to extend approxi-
mately 5 mm caudal to that point, running parallel to the 
fourth ventricle and to the cerebral aqueduct. 
 Toronto, Canada  [23, 24] . T1- and T2-weighted MRI 
sequences were obtained. The target region was defined 
as being 4–5 mm below the caudal aspect of the IC, 2–3 
mm posterior to the limit between the base and tegmen-
tum of the pons in the anteroposterior axis, and 3–4 mm 
medial to the lateral edge of the brainstem. The final co-
ordinates were modified according to individual anatom-
ical variations and by intraoperative findings. This target 
area represents the position of the lowest contact on the 
Medtronic 3387 DBS electrode. As the electrode has 4 
contacts, the area of each of the other contacts, up to 10.5 
mm above this chosen target, can be used for testing and 
chronic stimulation. 
 Fig. 1. Axial sections perpendicular to the long axis of the brain-
stem. Row I: level of the rostral PPN and mid-IC (IA and IB: 36 
mm rostral to obex; IC and ID: 16 mm rostral to B-F plane). Row 
II: through the middle of the PPN (IIA and IIB: 33 mm rostral to 
obex; IIC and IID: 13 mm rostral to B-F plane). Row III: sections 
taken through the caudal PPN (IIIA and IIIB: 31 mm rostral to 
obex; IIIC and IIID: 11 mm rostral to B-F plane). Columns A and 
B: adapted from Paxinos and Huang  [54] . Column A presents neg-
ative photographs of sections stained with cresyl violet and acetyl-
cholinesterase: white matter appears dark, gray matter appears 
light. The line drawings presented in column B show the outline 
of fiber tracts and nuclei. The ventricular system is solid black, a 
number of structures relevant to the PPN have been assigned a 
color. Columns C and D: taken from Afshar et al.  [55] . Column C 
presents photomicrographs of modified Mulligan stain sections: 
white matter tracts appear light, gray matter is dark. Column D: 
stereotactic drawings based upon probability data acquired from 
multiple hemibrainstems (see text, and note the superimposed
stereotactic grid). Major structures are labeled, but the PPN is not 
amongst them. Surrounding structures have been assigned the 
same color scheme as in column B. Columns E and F: MRI images 
from a representative patient in the study acquired using the spe-
cifically modified proton density sequence described in the text. 
White matter appears hypointense and gray matter relatively hy-
perintense. Planning software was used to reconstruct axial im-
ages at a plane perpendicular to the midline of the fourth ventricu-
lar floor. Column F: interpretation of the structural arrangement 
of brainstem structures within the MR image assisted by the inher-
ent image contrast as well as an understanding of the regional anat-
omy. The PPN can be directly localized within the gray matter ly-
ing lateral to the superior cerebellar peduncle and its decussation 
(green) and central tegmental tract (blue) and medial to the lem-
niscal systems (yellow) and is represented by a red circle. Note: the 
atlas photographs and drawings reproduced here were originally 
published in conventional anatomical representation (anterior 
surface of the brainstem towards the bottom of the page). These 
images were purposefully rotated through 180° to make their ori-
entation analogous to the axial radiological imaging convention 
that is more familiar to clinicians. CTT/ctg = Central tegmental 
tract; LL/ll = lateral lemniscus; ML = medial lemniscus; PPN = pe-
dunculopontine nucleus; PPTgC = PPN pars compacta; PPTgD = 
PPN pars diffusa; SCP/scp = superior cerebellar peduncles; STT/
spth = spinothalamic tract. Illustrations in columns A and B re-
printed from Paxinos and Huang  [54] ; illustrations in columns C 
and D reprinted from Afshar et al.  [55] ; adapted from Zrinzo et al. 
 [29] , with permission.  
(For figure see next page.)
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 Oxford, UK  [25, 26] . Patients underwent echo planar 
and diffusion-weighted MR data acquisition and diffu-
sion tensor imaging. This allowed visualization of the
superior cerebellar decussation and medial lemniscus. In 
addition, a stereotactic CT scan of the whole head at 1.0-
mm contiguous slices was acquired. Using planning soft-
ware, the preoperatively acquired T2-weighted MRI scan 
was volumetrically fused to the stereotactic CT. The tar-
get chosen was the one delineated by diffusion tensor im-
aging. A trajectory was chosen along the long axis of the 
brainstem, from a level just below the red nucleus to the 
level below the IC, incorporating the seeded target site 
along the axis of implantation. 
 London, UK  [27–29] . Zrinzo and colleagues used in-
formation derived from proton density MRI sequences 
to obtain an optimized visualization of the PPN and ad-
jacent brainstem structures ( fig. 1 ). The rostral pole of 
the PPN was identified at the mid-IC level, whereas the 
caudal pole was suggested to lie in the rostral pons. Al-
together, the authors suggested that the PPN spans for a 
distance of 5 mm. The authors characterized fourth ven-
tricular landmarks, including the fastigial point, a line 
tangential to the floor of the fourth ventricle along the 
median sulcus (VFL), and a line perpendicular to the 
VFL passing through the fastigium. The intersection be-
tween these lines determined the base point. The axial 
plane to target the PPN was perpendicular to the VFL 
( fig. 2 ). 
 T1-weighted images were used to identify the land-
marks and proton density images to provide contrast 
within the brainstem. On axial proton density images re-
formatted with respect to fourth ventricular landmarks, 
the rostral PPN was characterized as a region of interme-
diate signal intensity bounded laterally by the medial lem-
niscus, spinothalamic tract, and lateral lemniscus, antero-
medially by the decussation of the superior cerebellar
peduncle and posteromedially by the central tegmental 
tract. On more caudal proton density axial images (5 mm 
inferior to the mid-IC level), the gray matter between the 
lemniscal system and the superior cerebellar peduncle 
was compressed to a narrow boomerang shape structure, 
and it was suggested that the caudal pole of the PPN oc-
cupies this slender gray matter region. Stereotactic im-
ages from 12 patients undergoing DBS of other brain tar-
gets were analyzed. Mean (and SD) coordinates for the 
visualized poles of the PPN in relation to the base point-
fastigial (B-F) plane were derived. The rostral pole of the 
PPN was found to be 6 (0.5) mm lateral to the midline, 
and 4.2 (0.8) mm anterior and 19.3 (1.4) mm rostral to the 
base point. The caudal pole was 6.8 (0.5) mm lateral, 4.4 
(0.5) mm anterior to B, and 14.3 (1.4) mm rostral to the 
B-F plane. 
 Mean (and SD) coordinates of the MRI-localized PPN 
poles in relation to the anterior-posterior commissure 
(AC-PC) plane were as follows: rostral pole 6.0 (SD 0.5) 
mm lateral and 3.0 (1.1) mm posterior to the PC, and 9.0 
(1.1) mm caudal to the AC-PC plane. The caudal pole was 
6.8 (0.5) mm lateral and 4.0 (1.1) mm posterior to the PC, 
and 13.9 (1.2) mm caudal to the AC-PC plane. Coordi-
nates of the PPN midpoint were 6.4 (0.5) mm lateral, 3.5 
(1.0) mm posterior, and 11.4 (1.2) mm caudal to the PC. 
The authors indicated that there was considerable varia-
tion in the location of the PPN in relation to both third 
 Fig. 2. Atlas-based landmarks of the fourth ventricle as defined in 
the stereotactic atlas of the human brainstem and cerebellum by 
Afshar et al.  [55] . Variability in the angle of the mesencephalic 
flexure (a) may lead to increased variability in the spatial relation-
ship of brainstem structures to the traditional AC-PC line. Brain-
stem structures may therefore enjoy a more constant relationship 
with fourth ventricular landmarks. A line is drawn tangentially to 
the floor of the fourth ventricle in the midline (VFL); a second line 
passes through the fastigium, perpendicular to the first. The inter-
section of these two lines (B) and the fastigial point (F) define two 
points in a new reference plane in a similar manner to that defined 
by the more traditional AC-PC points. Extensions of the VFL and 
the AC-PC line subtend an angle a: the mesencephalic angle. 
Adapted from Zrinzo et al.  [29] , with permission.  
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and fourth ventricular landmarks. They also pointed out 
that atlas-based coordinates would be useful in providing 
an estimate of PPN localization, but that further refine-
ment by MRI would be needed. 
 Proof of principle of this method was also demonstrat-
ed by histologically verified accurate lead placement 
within the PPN bilaterally in a single cadaver study  [28] . 
 Rome, Italy  [30, 31] . CT sections corresponding to an 
axial plane located 5 mm below the pontomesencephalic 
junction were obtained. The target was then located at a 
point within that section that was 7 mm in front of (lat-
eral to) the wall of the pontine tegmentum. Investigators 
in Rome also used: (1) ventriculography; (2) angio-CT 
scans (axial planes), and (3) 3-dimensional (3D) recon-
structions of brainstem atlases. As the trajectory was pref-
erably extraventricular, the angles most commonly used 
ranged from 8 to 11° in the coronal plane and 25° in the 
sagittal plane, being as parallel as possible to the floor of 
the fourth ventricle. 
 Grenoble, France  [32] . In Grenoble, investigators used 
ventriculography and MRI though there were changes in 
methodology which evolved over several years. Average 
coordinates of the tentative target were 1.5 mm posterior 
to the PC, 13 mm below the AC-PC line, and 6 mm lat-
eral from the midline. The tentative trajectory was paral-
lel to the floor of the fourth ventricle. In the first 6 pa-
tients, the PPN was targeted based on bi-orthogonal tele-
ventriculographic images, which allowed the localization 
of ventricular landmarks (AC, PC and aqueduct/floor of 
the fourth ventricle). These were fused with T1- and T2-
weighted 1.5-tesla MR scans. A central trajectory was 
chosen to be parallel to the floor of the fourth ventricle, 
passing through the PC with a 14- to 20-degree mediolat-
eral angle. The target depth was set at 13 mm below the 
PC and 6 mm from the midline. A second trajectory was 
defined 2 mm posterior to the central one. A third trajec-
tory was occasionally performed 2 mm anterior or lateral 
to the central trajectory. In the next 5 patients, a target 
was chosen that was 2–3 mm posterior to the PC, 6 mm 
from the midline, at the level of the pontomesencephalic 
junction (PMJ), with an angle adapted to the brainstem 
orientation. Targeting was supported by using a brain-
stem-normalized coordinate system that accounted for 
the PMJ and its width as the craniocaudal and anteropos-
terior references, respectively. 
 San Francisco, USA  [33] . This group targeted the PPN 
based on MRI at a point superolateral to the decussation 
of the superior cerebellar peduncles on T2-weighted fast 
spin echo images. Average coordinates were 6–7.5 mm 
lateral, 13–15 mm inferior, and 15–17 mm posterior to 
the midcommissural point. With respect to brainstem-
based coordinate systems, target coordinates were 6–7.5 
mm lateral, 3–5 mm anterior to the base point, and 13–16 
mm rostral to the B-F plane. When appropriate, the target 
was adjusted so that it would be 2–3 mm away from the 
lateral edge of the brainstem, at the level of the PMJ. 
 Brisbane, Australia  [34] . After CT/MRI fusion, the 
PPN was targeted on MRI in stereotactic space with the 
concomitant use of reconstructions from brainstem at-
lases. The PPN was identified lateral to the superior cer-
ebellar decussation and below the level of the IC. Trajec-
tories were parallel to the axis of the brainstem and fourth 
ventricle, passing through the subthalamic region poste-
rior to the red nucleus. 
 Hannover, Germany  [17] . In Hannover, targeting was 
conducted based on T1- and T2-weighted MRI images 
fused with stereotactic CT. A combination of 3 different 
methods was used: (1) image-guided indirect determina-
tion of the PPN after the visualization of neighboring 
structures (decussation of the superior cerebellar pedun-
cles and medial lemniscus); (2) preliminary definition of 
the midpoint of the PPN in relation to the AC-PC plane: 
6–7 mm lateral, 3–4 mm posterior to the PC, and 11–13 
mm below the AC-PC plane; (3) preliminary definition 
of the rostral and the caudal poles of the PPN according 
to the method of Afshar (rostral pole: 6 mm lateral and 4 
mm anterior to the base point, 16 mm rostral to the base 
B-F plane; caudal pole: 7 mm lateral and 4 mm anterior 
to the base point, 11 mm rostral to the B-F plane). The 
coordinates obtained by all 3 methods were then com-
pared and adapted. The final target for the lowest elec-
trode contact was the caudal pole of the PPN. 
 Paris, France  [12] . The PPN was targeted using an MRI 
and a 3D histological atlas of the basal ganglia that were 
deformed to the preoperative T1-weighted MRI. A set of 
coordinates was obtained with each method, aiming for 
the lowest contact to be just outside the lower limit of the 
nucleus. The tentative target was defined by averaging 
these coordinates. Trajectories were selected taking into 
account the size of the brainstem and also avoiding the 
ventricles, caudate nuclei, and blood vessels. 
 Conclusions 
 Most authors advocate T2-weighted and proton den-
sity sequences for direct visualization of landmarks in the 
PPN region. The PPN target lies medial to the medial 
lemniscus, close to the lateral edge of the superior cerebel-
lar commissure and lateral to the central tegmental tract. 
In the rostrocaudal axis, it straddles the PMJ with its ros-
tral pole located at the level of the mid-IC. 
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 Most groups choose trajectories parallel to the floor of 
the fourth ventricle. According to some investigators, an 
appropriate dorsoventral landmark for placing the tip of 
the electrodes is a region 5 mm below the inferior edge of 
the IC (immediately inferior to the transition between 
midbrain and pons). The B-F system can be used for tar-
geting but has only been validated by a few groups. 
 There is general agreement that indirect targeting 
based on the AC-PC plane only is problematic. Neverthe-
less, the reported average coordinates relative to the AC-
PC plane are the following: 6–7.5 mm lateral, 13–15 mm 
inferior, and 15–17 mm posterior to the AC-PC midpoint 
(or 1.5 mm posterior to the PC). A few authors also ad-
vocate that, in the medial lateral plane, the electrode tip 
should be placed in a region 2–4 mm medial to the lat-
eral edge of the brainstem. Since the caudal extent of the 
PPN is unclear, some authors suggest placing the tip of 
the electrode 4 mm below the PMJ. 
 In conclusion, a variety of imaging protocols were 
used to approach the PPN. Although the target appears 
to be similar across studies, there is no consensus as to 
which protocol would be most appropriate. 
 Microelectrode Recording 
 Electrophysiological Features of the PPN Region and 
Target Localization 
 Several groups reported the findings of microelectrode 
recording in the PPN region. The findings are summa-
rized below. 
 Toronto, Canada  [24] . In the study by the Toronto 
group, a total of 244 neurons were classified according to 
the width and polarity of their action potentials in 7 pa-
tients (2 with progressive supranuclear palsy). Three pop-
ulations were described: (1) units that fired randomly at 
17 Hz (most cells); (2) neurons suggested as being cholin-
ergic based on the characteristics of their action poten-
tials (16% of the total number of cells firing at 9 Hz), and 
(3) units with positive action potentials that fired regu-
larly at a mean of 67 Hz (7% of cells). Most neurons (57%) 
fired randomly while 21% exhibited a bursty firing pat-
tern. Above and below the PPN, the proportion of burst-
ing neurons was smaller (11 and 19%, respectively), while 
more neurons exhibited random firing (65 and 75%, re-
spectively). Overall, 36% of the neurons responded to at 
least one type of passive or voluntary limb movement. 
Changes in firing rate were mostly excitatory (about 
80%). 
 Grenoble, France  [35, 36] . Among 21 cells recorded, 14 
(67%) fired irregularly, and 7 (33%) exhibited a burst-like 
pattern. The mean firing rate of all neurons was 28 Hz. 
During locomotor tasks, 57% of cells modified their fir-
ing. Of interest, 2 patients were asked to mimic stepping 
movements in the operating room. In those individuals, 
7 cells showed an increase in firing during mimicked gait. 
 San Francisco, USA  [33] . The mean spontaneous dis-
charge rate for neurons presumably within the PPN or 
dorsal to it was 23 and 35 Hz, respectively. Bursting dis-
charge was more prevalent in the PPN compared to more 
dorsal regions. Wide action potential neurons were seen 
in the region dorsal to the PPN, and in the dorsal part of 
the PPN itself, but not in caudal regions. In the region 
dorsal to the PPN, 44% of neurons had significant oscil-
latory activity, while this was only observed in 19% of cells 
within the PPN. Oscillation frequencies within the PPN 
tended to be higher than those recorded in dorsal regions. 
Responses to contralateral movements of the limbs were 
observed in 43% of units in the PPN region. Most units 
responded to passive movements with phasic increases in 
discharge. 
 Brisbane, Australia  [37] .  In a study from Brisbane, 686 
cells were recorded from 11 patients (10 with PD and 1 
with progressive supranuclear palsy). Neurons were di-
vided into narrow (87%) or wide-spike units (13%). Mean 
firing rates in both populations were 12–13 Hz. In narrow 
units, 16% of firing occurred in bursts, versus 46% in wide 
firing units. Wide units were more prominent in the cau-
dal PPN and suggested to be cholinergic. Although 
around half of the cells recorded in this study were move-
ment responsive, most units showed a decrease in firing 
(in contrast to other reports in the field). Interestingly, 
certain cells were inhibited during imaginary gait. 
 Conclusions 
 Most neurons in the PPN region seem to fire in a range 
between 12 and 30 Hz in patients with PD. There are how-
ever subpopulations that fire at lower (9 Hz; possible cho-
linergic cells) and higher rates (60–70 Hz). Most cells fire 
randomly. Around 20–30% of units fire in bursts, which 
are more commonly recorded in the presumed PPN than 
dorsal to it. 
 Around 35–45% (perhaps more) of cells in the PPN 
region respond to passive or active movements. Some 
cells respond to movements that mimic gait patterns. 
The phenotype of cells recorded is unclear, and the exact 
nuclear region where the cells were recorded has also 
been difficult to pinpoint (PPN, cuneiform, or subcune-
iform). 
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 Intraoperative PPN Region Test Stimulation 
 Electrodes, Stimulation Parameters, Effects, and
Side Effects 
 According to published data, most groups do not use 
microstimulation to assess thresholds for possible side ef-
fects induced by electrical stimulation. 
 Based on the Grenoble experience in awake patients 
 [36] , stimulation induced no effect on akinesia, rigidity or 
tremor. Furthermore, no effects were observed during a 
task in which patients were asked to pedal while in the 
supine position. However, microstimulation was used to 
delineate neighboring structures. Stimulation was ap-
plied every 3 mm from –5 to –15 mm below the AC-PC 
plane. Stimulation parameters were: frequencies of 25 
and 130 Hz, a pulse width of 0.06 ms, and current intensi-
ties of 0.1 up to 4 mA. Stimulation induced the following 
effects depending on frequency: mono- and binocular 
movements (such as eye deviation or trembling vision) at 
both 25 and 130 Hz, mostly present when stimulation was 
delivered at the rostral level of the IC; myoclonic move-
ments/muscular vibratory-like sensations at 25 Hz; par-
esthesias, mainly at 130 Hz, when stimulation was deliv-
ered laterally, around 6–7 mm from the midline. 
 Sites in which monocular deviation and paresthesias 
were recorded at 25 Hz at a low amplitude were avoided 
for lead implantation. Best clinical outcomes were ob-
tained when 130-Hz microstimulation induced only 
transient paresthesias on the contralateral face and upper 
limb, and when 25 Hz induced myoclonic movements/
muscular vibration-like sensations at the PMJ level. Some 
authors have suggested that this could be a possible target 
signature. 
 The Brisbane group reported stimulation-induced 
sleep when current was delivered at 100–130 Hz to the 
rostral PPN  [38] . Other side effects included disturbances 
with ocular pursuit and saccades, with reports of shim-
mering in the visual fields. 
 Conclusions 
 Reported stimulation-induced effects in the operating 
room include oscillopsias, paresthesias, and myoclonic 
movements. 
 What Type of DBS Electrode to Implant  
 Both the Medtronic 3387 and the Medtronic 3389 DBS 
electrodes have been used (Medtronic Inc., Minneapolis, 
Minn., USA). The advantage of the 3387 is that, with a 
wider span of the contacts, a broader anatomical coverage 
is possible. Since the PPN is partially degenerated in PD 
(and more so in progressive supranuclear palsy  [39–41] ), 
one may advocate that smaller-spaced electrodes might 
be preferable. Given the length of the PPN region and the 
uncertainty about the optimal stimulation site, the Ox-
ford group favors the 3387 electrode. Since the Brisbane 
group concentrated on the more caudal region of the 
PPN, the 3389 model was used. 
 Conclusions 
 To date, there is no data suggesting that one electrode 
is better than the other for stimulating the PPN region. 
 Local Field Potentials  
 Several studies have explored local field potentials in 
the PPN region, intraoperatively from microelectrodes 
 [24, 33] or postoperatively from externalized DBS elec-
trodes  [38, 42] . Overall results have been heterogeneous 
with patients showing peaks in the theta, alpha or beta 
frequency bands  [24, 33, 38, 42] . One study suggested that 
this variability could be related to electrode location, with 
alpha and beta activity being more marked in the caudal 
and rostral PPN, respectively  [38] . The San Francisco 
group demonstrated that, as the electrode was advanced, 
the percentage of power in the low beta range (13–21 Hz) 
increased from 35.2 to 40.8% at rest, and from 11.1 to 
29.8% during movement  [24, 33] . In a few studies, local 
field potentials were shown to respond to limb movement 
 [33, 42] and to correlate with gait (e.g. alpha band)  [38] . 
In a study from Oxford, only the caudal alpha activity cor-
related with gait and freezing of gait whilst rostral beta 
activity did not  [38] . Changes in electrophysiological ac-
tivity were observed after  L -dopa administration  [43] and 
related to movement initiation  [42] . Tattersall et al.  [37] 
have recently demonstrated that alpha power was signifi-
cantly higher relative to beta power in the caudal PPN. 
These authors have also found an increase in both alpha 
and beta power (alpha/beta power ratio) during limb 
movements. Relatively less attention has been paid to 
gamma band activity  [44] . 
 Additionally, somatosensory evoked potentials were 
recorded from implanted PPN electrodes  [30, 45–47] . 
Yeh et al.  [48] recorded somatosensory evoked potentials 
after median nerve stimulation. These were triphasic or 
biphasic potentials with latencies to the largest negative 
peak in the order of 16.8 and 18.7 ms. There was no dif-
ference in somatosensory evoked potential amplitude 
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and latency between on- and off-medication states. High-
frequency oscillations could be identified after the con-
tralateral median nerve had been stimulated. 
 As part of the reticular activating system, the PPN may 
also respond directly to sensory inputs  [20] . In humans, 
the midlatency auditory evoked P50 potential recorded at 
the vertex has been proposed to be generated by the PPN 
 [49] , but such studies have not been carried out in PD pa-
tients  [50] . 
 Conclusions 
 Frequency bands in the alpha, beta, and theta ranges 
and movement-related potentials were all recorded from 
the PPN region. In the off-medication condition, beta de-
synchronization occurred during movement in a small 
study. In the on-medication condition, oscillations in the 
7- to 11-Hz range were recorded. Beta-related synchroni-
zation occurred during premovement phases, and theta-
related desynchronization occurred with movement. 
 It may be important to develop a standard set of rest-
ing and movement-related intraoperative local field po-
tentials that might help to optimize PPN targeting. One 
problem is that the alpha band activity correlating with 
gait may not be evident when patients are lying supine.
 Intraoperative and Early Postoperative 
Complications 
 Adverse Effects and Management 
 Until recently, there have been no reports of serious 
adverse events either intraoperatively or in the early post-
operative period after PPN DBS in more than 100 pub-
lished patients. The report from the Paris group, however, 
reported 2 severe complications  [11, 12] . Symptomatic 
bleeding occurred in 1 patient, who developed a midbrain 
hematoma, followed by impairment of consciousness. 
After recovery, he was discharged, wheel-chair bound, 
anarthric and had to be fed via gastrostomy. Another pa-
tient had an infection that required removal of the DBS 
system 1 month after surgery. He recovered without se-
quelae but decided not to be re-implanted. 
a
b
c
 Fig. 3. Location of DBS electrodes in the PPN region in a patient 
from the Grenoble group.  a Sagittal fusion imaging of the final in-
traoperative teleradiography with the preoperative MRI, showing 
how the coordinates of the tip of the distal contacts of the elec-
trodes were measured. h = Distance (in millimeters) to the ponto-
mesencephalic (PM) line, defined as the line connecting in the an-
terior-posterior direction the PMJ to the caudal end of the quadri-
geminal plate, measured on the midline; AC = anterior commissure; 
PC = posterior commissure; d = orthogonal distance in millimeters 
to the line prolonging the fourth ventricle line; V4 = fourth ven-
tricle.  b 3D T1-weighted MRI in the axial plane parallel to the bi-
commissural plane, at the level of contacts 1 and 5 of the electrodes. 
Those contacts delivered cathodic current, and the contact depth 
of the right and left electrodes was symmetrical.  c Atlas adaptation 
onto the patient’s MRI. Superior posterior view of the 3D image 
with the PPN in pink, the medial lemniscus in white and the 4 elec-
trode contacts in blue. Note that in this patient the electrode is lo-
cated posterior to the PPN. Adapted from Ferraye et al.  [16] , with 
permission.  
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 Overall, available data suggest that PPN DBS surgery 
has a safety profile that is similar to other targets which 
are being used in PD; however, it should be noted that 
these findings may be underestimated due to a reporting 
bias. 
 Stimulation-induced adverse events in the early post-
operative period included oscillopsia, paresthesias, burn-
ing sensations, myoclonus, sleep induction, and inconti-
nence  [32, 38, 51] . These phenomena were time locked 
with stimulation, they were frequency dependent, and 
were reversible when stimulation was reduced or ceased. 
 Conclusions 
 Available evidence suggests that surgery for implanta-
tion of electrodes in the PPN is relatively safe and, in gen-
eral, well tolerated. 
 Postoperative Imaging 
 Examination of postoperative figures from published 
studies reveals that in most instances electrodes were im-
planted in apparently the same anatomical region al-
though many studies do not provide much detail. There 
is both variation in the anteroposterior axis and in the 
depth of lead placement relative to the PMJ. When assess-
ing coordinates and the exact numbers, it is difficult to 
reach uniform conclusions. Some studies reported the lo-
cation of the tip of the electrodes, while others described 
the position of contacts 0 or 2. Further, studies have used 
different landmarks when assessing their data, including 
the AC-PC or the B-F system. Another issue is that, even 
when electrodes were placed in apparently the same 
brainstem region, patients were stimulated through dif-
ferent contacts (some in the caudal PPN, others in the 
rostral PPN)  [6–8, 13, 17, 22, 23, 25, 28, 30, 52, 53 ] .
 Some MR sequences produce large lead artifacts and 
only poor internal tissue contrast within the brainstem. 
This may limit the accurate determination of the localiza-
tion of the lead ( fig.  3 )  [16] . Nevertheless, MRI is cur-
rently the most useful method to localize and to confirm 
electrode placement in the PPN region as well as to docu-
ment its variability ( fig. 4 )  [36, 38] . 
 Conclusions 
 A wide variety of techniques were employed to docu-
ment lead location following PPN DBS. CT imaging can-
not account for individual anatomical variability and re-
quires coregistration with atlases or MR images. Although 
most authors used MRI, sequences were often not report-
ed in detail. Poor tissue contrast within the region of in-
terest appears to be a general problem, and this adds to 
the difficulty in identifying internal anatomical land-
marks. Stereotactic MRI using proton density sequences 
seems to be of value for documenting lead placement in 
the PPN region postoperatively.
 Challenges and Future Prospects 
 PPN DBS is a relatively novel intervention in PD. Our 
data here demonstrate the wide ranges in almost all 
fields which were investigated. There are a number of 
important challenges to be resolved such as identifica-
tion of the optimal target, the choice of the surgical ap-
proach to optimize electrode placement, impact on out-
come of specific surgical techniques, reliability of intra-
operative confirmation of the target, and methodological 
differences in postoperative validation of the electrode 
position. There is considerable variability both within 
and across groups, the overall experience with PPN DBS 
is still limited, and there is a lack of controlled trials. De-
spite these challenges, the procedure seems to provide 
benefit to selected patients and appears to be relatively 
safe. 
 There is uncertainty of the future role of PPN DBS in 
the armamentarium of surgery for patients with PD. 
There is some risk that the benefits of this procedure 
 Fig. 4. Location of active stimulation sites within the PPN region 
mapped on a sagittal T1-weighted MR scan. Adapted from The-
vathasan et al.  [15] , with permission. 
D
ow
nl
oa
de
d 
by
: 
R
ad
bo
ud
 U
ni
ve
rs
ite
it 
Ni
jm
eg
en
    
    
    
    
    
    
  
13
1.
17
4.
24
8.
45
 - 
3/
14
/2
01
7 
12
:2
1:
42
 P
M
 Hamani   et al.
 
Stereotact Funct Neurosurg 2016;94:307–319
DOI: 10.1159/000449011
318
would not be fully appreciated, since there has also been 
doubt about its overall efficacy and about its clear-cut 
benefits. Certainly, more studies are needed providing 
more solid data on the advantages and limits of chronic 
stimulation. One important limitation in comparing 
studies from different centers and analyzing outcome is 
the great variability in targeting and surgical techniques, 
as shown in our paper. 
 By systematically reviewing the published data, we 
identified several challenges which will be of relevance 
when designing future studies to better address contro-
versial issues. We also hope that the data shown here may 
facilitate the development of surgical protocols for PPN 
DBS.
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